Latest Share Chat

REMOVE ADS

Ixico Share News (IXI)

Ixico Information

Share Price Information for Ixico (IXI)

Share Price is delayed by 15 minutes

Get Live Data

9.10 0.00 (0.00%)

Bid:

8.70

Ask:

9.50

Spread: 0.80 (9.195%)

Market Cap: £19.93m

Last checked at -

Intraday Ixico Share Chart

REMOVE ADS

Ixico secures new contract with US-based client

Tue, 10th Dec 2024 10:45

(Sharecast News) - Neuroscience imaging firm Ixico has signed a contract with a new US-based client to provide imaging services for a Phase 2 Huntington's Disease clinical trial.

Ixico said on Tuesday that the contract value, which will be delivered over approximately two and a half years, was worth more than £500,000 to the company.

The AIM-listed firm added that the contract award reinforced its "sustained positive commercial momentum" and aligns with its strategic pillars to drive expansion and growth.

Chief executie Bram Goorden said: "We are delighted to announce our involvement in this Phase 2 clinical trial, which aims to address the urgent need for effective treatments for Huntington's disease.

"This contract further demonstrates Ixico's expertise in supporting neurodegenerative disease trials, reinforcing our role as a trusted partner for sponsors."

As of 1045 GMT, Ixico shares were up 0.093% at 10.76p.

Reporting by Iain Gilbert at Sharecast.com